opc 21268 has been researched along with Hypertension, Renal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tuchida, H; Yamada, K; Yoshida, S | 1 |
1 other study(ies) available for opc 21268 and Hypertension, Renal
| Article | Year |
|---|---|
A lack of anti-hypertensive effect of an orally effective V1 receptor antagonist, OPC-21268, in end-stage renal disease.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Middle Aged; Piperidines; Quinolones | 1993 |